4:06 PM
 | 
Dec 01, 2017
 |  BioCentury  |  Finance

Opportunity sizing

Why Athyrium and Neuberger scaled up their third fund

With strong support from existing and new LPs and an attractively priced healthcare sector to play in, Athyrium Capital Management and Neuberger Berman went big for their third co-managed fund.

Athyrium Opportunities Fund III clocked in at just over $2 billion, nearly 1.7x the size of its predecessor’s $1.2 billion haul and a fourfold increase from the initial $507 million fund.

Athyrium’s Jeffrey Ferrell said the fund’s strategy won’t change: it will continue to back commercial-stage companies across the healthcare ecosystem.

Based on the earlier funds’ allocations, Ferrell...

Read the full 418 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >